Clinical study and outcome of rhino-orbital mucormycosis patients
Objectives: To know the clinical presentation and outcome of rhino-orbital cerebral mucormycosis during the limited availability of facilities during the acute surge of COVID-19 pandemic. Method: We conducted a retrospective, non-interventional observational study on 55 patients with rhino-orbital c...
Main Authors: | A R Suresha, Swati S Sonwalkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Kerala Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.kjophthal.com/article.asp?issn=0976-6677;year=2023;volume=35;issue=3;spage=278;epage=283;aulast=Suresha |
Similar Items
-
Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
by: Ramesh Murthy, et al.
Published: (2022-01-01) -
The Role of Retrobulbar Injection of Amphotericin B in the Management of Orbital Mucormycosis in a Tertiary Care Centre—Prospective Analytical Study
by: A Yogeswari, et al.
Published: (2023-01-01) -
Clinical profile of COVID-19-associated mucormycosis patients and the clinical suspects: a descriptive audit
by: Sophia Amalanathan, et al.
Published: (2023-04-01) -
Endovascular Infusion of Amphotericin B for the Treatment of Rhino-Orbito-Cerebral Mucormycosis: A Pilot Study Assessing Technical Feasibility and Safety
by: Subhash Kumar, et al.
Published: (2022-07-01) -
Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report
by: Yang Zhou
Published: (2024-02-01)